Abstract
The objectives of this study were to compare the patient's (PtGDA) and physician's (PhGDA) assessment of global disease activity and to identify factors that might influence these differences as well as factors that may influence the patient's and the physician's scores separately. Anonymous data were used from 2,117 Dutch patients included in the Measurement of efficacy of Treatment in the Era of Rheumatology database. PtGDA and PhGDA were scored independently on a 100-mm visual analog scale (VAS) with 0 and 100 as extremes. The agreement, intraclass correlation coefficients (ICC), was calculated and a Bland–Altman plot was created to visualize the differences between PtGDA and PhGDA. Linear mixed model analysis was used to model PtGDA and PhGDA. Logistic repeated measurements were used to model the difference in PtGDA and PhGDA (PtGDA > PhGDA versus PtGDA ≤ PhGDA). Gender patient, gender physician, age, swollen joint count (SJC), tender joint count, VAS pain, disease duration, and erythrocyte sedimentation rate (ESR) were considered as possible determinants in both models. Mean (standard deviation) age was 57 (15) years and 67 % of the patients were female. Agreement between PtGDA and PhGDA was moderate (ICC, 0.57). Patients scored on average 11 units higher (worse) than rheumatologists (95 % limits of agreement, −25.2 to 47.6). Patient's perception of pain (VAS) was positively associated with a PtGDA being higher than PhGDA. Similarly, ESR and swollen joint counts were positively associated with a PtGDA being lower or equal to the PhGDA. Patients rate global disease activity consistently higher than their rheumatologists. Patients base their judgment primarily on the level of pain, physicians on the level of SJC and ESR.
Similar content being viewed by others
References
Otter SJ, Lucas D, Springett K, Moore A, Davies K, Young A et al (2012) Identifying patient–reported outcomes in rheumatoid arthritis: the impact of foot symptoms on self–perceived quality of life. Musculoskelet Care 10:65–75
Hewlett SA (2003) Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 30(4):877–879
Suarez-Almazor ME, Conner-Spady B, Kendall CJ, Russell AS, Skeith K (2001) Lack of congruence in the ratings of patients' health status by patients and their physicians. Med Decis Making 21(2):113–121
Wartman SA, Morlock LL, Malitz FE, Palm E (1983) Impact of divergent evaluations by physicians and patients of patients' complaints. Public Health Rep 98(2):141–145
Khan NA, Spencer HJ, Abda E, Aggarwal A, Alten R, Ancuta C et al (2012) Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity. Arthritis Care Res 64(2):206–214
Nicolau G, Yogui MM, Vallochi TL, Gianini RJ, Laurindo IM, Novaes GS (2004) Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity. J Rheumatol 31(7):1293–1296
Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F et al (2009) Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 11(1):R7
Weisman CS, Teitelbaum MA (1985) Physician gender and the physician-patient relationship: recent evidence and relevant questions. Soc Sci Med 20(11):1119–1127
Foti C, Cisari C, Carda S, Giordan N, Rocco A, Frizziero A et al (2011) A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate in synovial joints with osteoarthritis. Eur J Phys Rehabil Med 47(3):407–415
Barton JL, Imboden J, Graf J, Glidden D, Yelin EH, Schillinger D (2010) Patient–physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res 62(6):857–864
Kwoh CK, O'Connor GT, Regan-Smith MG, Olmstead EM, Brown LA, Burnett JB et al (1992) Concordance between clinician and patient assessment of physical and mental health status. J Rheumatol 19(7):1031–1037
Ward M (1994) Clinical measures in rheumatoid arthritis: which are most useful in assessing patients? J Rheumatol 21(1):17–27
Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR (2000) Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 27(3):675–679
Liang M, Cullen K, Larson M (1982) In search of a more perfect mousetrap (health status or quality of life instrument). J Rheumatol 9(5):775–779
Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26(11):1346–1353
Ward MM (2004) Rheumatology care, patient expectations, and the limits of time. Arthritis Rheum 51(3):307–308
Vermeer M, Kuper HH, van der Bijl AE, Baan H, Posthumus MD, Brus HL et al (2012) The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion. Rheumatology (Oxford) 51(6):1076–1080
Pyne L, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC et al (2012) Increasing Treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study. J Rheumatol 39(11):2081–2087
Acknowledgments
This work was supported by Pfizer
Disclosure
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gvozdenović, E., Koevoets, R., Wolterbeek, R. et al. Assessment of global disease activity in RA patients monitored in the METEOR database: the patient's versus the rheumatologist's opinion. Clin Rheumatol 33, 461–466 (2014). https://doi.org/10.1007/s10067-013-2390-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2390-4